HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade

DM Woods, AL Sodré, A Villagra, A Sarnaik… - Cancer immunology …, 2015 - AACR
Expression of PD-1 ligands by tumors and interaction with PD-1–expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this coinhibitory axis …
被引用次数：450 相关文章

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.

DM Woods, AL Sodré, A Villagra, A Sarnaik… - Cancer Immunology …, 2015 - europepmc.org
Expression of PD-1 ligands by tumors and interaction with PD-1 expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this co-inhibitory axis …

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

DM Woods, AL Sodré, A Villagra… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Expression of PD-1 ligands by tumors and interaction with PD-1-expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this coinhibitory axis …
[PDF] psu.edu

[PDF][PDF] HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

DM Woods, AL Sodré, A Villagra, A Sarnaik… - Citeseer
Expression of PD-1 ligands by tumors and interaction with PD-1 expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this co-inhibitory axis …
[PDF] researchgate.net

[PDF][PDF] HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

DM Woods, AL Sodré, A Villagra, A Sarnaik… - researchgate.net
Expression of PD-1 ligands by tumors and interaction with PD-1 expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this co-inhibitory axis …
[HTML] nih.gov

[HTML][HTML] HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

DM Woods, AL Sodré, A Villagra… - Cancer immunology …, 2015 - ncbi.nlm.nih.gov
Expression of PD-1 ligands by tumors and interaction with PD-1 expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this co-inhibitory axis …

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

DM Woods, AL Sodré, A Villagra, A Sarnaik… - Cancer Immunology …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Expression of PD-1 ligands by tumors and
interaction with PD-1–expressing T cells in the tumor microenvironment can result in …

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.

DM Woods, AL Sodré, A Villagra, A Sarnaik… - Cancer Immunology …, 2015 - europepmc.org
Expression of PD-1 ligands by tumors and interaction with PD-1 expressing T cells in the
tumor microenvironment can result in tolerance. Therapies targeting this co-inhibitory axis …